TCTAP A-001 Thirty-day Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients Presenting with Acute Coronary Syndromes Versus Stable Coronary Artery Disease: Results from the Italian RAI Registry

Acute coronary syndrome (ACS) has shown to increase the risk of drug eluting stent (DES) thrombosis and to date, data on PCI with BVS implantation in patients presenting with acute coronary syndromes (ACS) are still limited. Methods RAI (Clinical Trials. gov Identifier: NCT02298413) is an Italian, p...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 69; no. 16; p. S1
Main Authors Moscarella, Elisabetta, Varricchio, Attilio, Ielasi, Alfonso, Cortese, Bernardo, De Angelis, Maria Carmen, Loi, Bruno, Tarantini, Giuseppe, Pisano, Francesco, Durante, Alessandro, Facchin, Michela, Colombo, Alessandro, Moretti, Luciano, Tumminello, Gabriele, Calabrò, Paolo, Corrado, Donatella, Steffenino, Giuseppe
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 25.04.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acute coronary syndrome (ACS) has shown to increase the risk of drug eluting stent (DES) thrombosis and to date, data on PCI with BVS implantation in patients presenting with acute coronary syndromes (ACS) are still limited. Methods RAI (Clinical Trials. gov Identifier: NCT02298413) is an Italian, prospective, multicentre registry not funded by the manufacturer, whose aim is to investigate BVS performance through a 5-year follow-up of all consecutive patients who have undergone successful implantation of...
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.03.026